510(k) K202174

Digital NeuroPort Biopotential Signal Processing System by Blackrock Microsystems — Product Code GWL

K202174 is an FDA 510(k) premarket notification submitted by Blackrock Microsystems for the device "Digital NeuroPort Biopotential Signal Processing System". The FDA issued a decision of Substantially Equivalent on Feb 10, 2021. The device falls under product code GWL (Amplifier, Physiological Signal), a Class II device regulated under 21 CFR 882.1835. Blackrock Microsystems has 2 other 510(k) clearances on record.

Clearance details

Decision
SESE (Substantially Equivalent)
Decision Date
Feb 10, 2021
Date Received
Aug 4, 2020
Clearance Type
Special
Expedited Review
No
Third Party Review
No

Device classification

Device Name
Amplifier, Physiological Signal
Device Class
Class II
Regulation Number
882.1835
Review Panel
NE
Submission Type
510(k)

Need the full FDA record for Blackrock Microsystems? Ask Claude or ChatGPT with the RegDataLab connector and get every site's inspections, Form 483s, warning letters, recalls and import alerts, each with a link to the FDA source. The API key is free: no card.

Get a free API key

How the connector works

Source: FDA 510(k) database entry for K202174. Report a data issue: hello@regdatalab.com.